08 February 2021 : Clinical Research
No COVID-19 Cases Detected Between April and September 2020 After Screening All 838 Admissions to a Maternity Unit in Poland
Paweł Piekarski1ABCDEF*, Małgorzata Sateja1BCF, Tomasz Maciejewski1DE, Tadeusz Issat1DEDOI: 10.12659/MSM.929123
Med Sci Monit 2021; 27:e929123
Table 1 Results of the routine reverse transcription-polymerase chain reaction test screening and the comorbidities in the 838 women admitted for labor.
| Investigated variable | n (%) |
|---|---|
| COVID-19-positive | 0 (0.0) |
| High-risk of COVID-19 | 2 (0.24) |
| Inconclusive results | 4 (0.48) |
| No comorbidities | 657 (78.4) |
| Gestational diabetes | 120 (14.3) |
| Pregestational diabetes | 2 (0.2) |
| Pregnancy-induced hypertension | 25 (3.0) |
| Pre-pregnancy hypertension | 9 (1.1) |
| Other* | 25 (3.0) |
| Obesity (BMI ≥30) | 224 (26.7) |
| Obesity class II (BMI 35.0–39.9) | 40 (4.8) |
| Obesity class III (BMI ≥40) | 16 (1.9) |
| * Hypothyroidism, asthma, mucoviscidosis, human immunodeficiency virus. BMI – body mass index. | |